OBJECTIVE: To examine the effect of an oxidized extracellular oxidation-reduction (redox) state (E(h)) on the expression of NADPH oxidases in vascular cells. METHODS AND RESULTS: The generation of reactive oxygen species by NADPH oxidase (Nox)-based NADPH oxidases activates redox-dependent signaling pathways and contributes to the development of "oxidative stress" in vascular disease. An oxidized plasma redox state is associated with cardiovascular disease in humans; however, the cellular mechanisms by which the extracellular redox state may cause disease are not known. Aortic segments and cultured aortic smooth muscle cells were exposed to E(h) between -150 mV (reduced) and 0 mV (oxidized) by altering the concentration of cysteine and its disulfide, cystine, the predominant redox couple in plasma. A more oxidized E(h) increased the expression of Nox1 and resulted in Nox1-dependent proliferation of smooth muscle cells. Oxidized E(h) rapidly induced epidermal growth factor receptor phosphorylation via shedding of epidermal growth factor-like ligands from the plasma membrane and caused extracellular signal-regulated kinase 1/2-dependent phosphorylation of the transcription factors activating transcription factor-1 and cAMP-response element-binding protein. Inhibition of epidermal growth factor receptor or extracellular signal-regulated kinase 1/2 activation, or addition of small interference RNA to activating transcription factor-1, prevented the increase in Nox1 expression. CONCLUSIONS: Our results identify a novel mechanism by which extracellular oxidative stress increases expression and activity of Nox1 NADPH oxidase and contributes to vascular disease.
OBJECTIVE: To examine the effect of an oxidized extracellular oxidation-reduction (redox) state (E(h)) on the expression of NADPH oxidases in vascular cells. METHODS AND RESULTS: The generation of reactive oxygen species by NADPH oxidase (Nox)-based NADPH oxidases activates redox-dependent signaling pathways and contributes to the development of "oxidative stress" in vascular disease. An oxidized plasma redox state is associated with cardiovascular disease in humans; however, the cellular mechanisms by which the extracellular redox state may cause disease are not known. Aortic segments and cultured aortic smooth muscle cells were exposed to E(h) between -150 mV (reduced) and 0 mV (oxidized) by altering the concentration of cysteine and its disulfide, cystine, the predominant redox couple in plasma. A more oxidized E(h) increased the expression of Nox1 and resulted in Nox1-dependent proliferation of smooth muscle cells. Oxidized E(h) rapidly induced epidermal growth factor receptor phosphorylation via shedding of epidermal growth factor-like ligands from the plasma membrane and caused extracellular signal-regulated kinase 1/2-dependent phosphorylation of the transcription factors activating transcription factor-1 and cAMP-response element-binding protein. Inhibition of epidermal growth factor receptor or extracellular signal-regulated kinase 1/2 activation, or addition of small interference RNA to activating transcription factor-1, prevented the increase in Nox1 expression. CONCLUSIONS: Our results identify a novel mechanism by which extracellular oxidative stress increases expression and activity of Nox1NADPH oxidase and contributes to vascular disease.
Authors: Salman Ashfaq; Jerome L Abramson; Dean P Jones; Steven D Rhodes; William S Weintraub; W Craig Hooper; Viola Vaccarino; R Wayne Alexander; David G Harrison; Arshed A Quyyumi Journal: Hypertension Date: 2008-05-26 Impact factor: 10.190
Authors: Mona Sedeek; Richard L Hébert; Chris R Kennedy; Kevin D Burns; Rhian M Touyz Journal: Curr Opin Nephrol Hypertens Date: 2009-03 Impact factor: 2.894
Authors: Moo Yeol Lee; Alejandra San Martin; Puja K Mehta; Anna E Dikalova; Abel Martin Garrido; S Raju Datla; Erin Lyons; Karl-Heinz Krause; Botond Banfi; J David Lambeth; Bernard Lassègue; Kathy K Griendling Journal: Arterioscler Thromb Vasc Biol Date: 2009-01-15 Impact factor: 8.311
Authors: Rebecca S Arnold; Ju He; Andrea Remo; Darren Ritsick; Qiqin Yin-Goen; J David Lambeth; Milton W Datta; Andrew N Young; John A Petros Journal: Am J Pathol Date: 2007-11-30 Impact factor: 4.307
Authors: Smita S Iyer; Carolyn J Accardi; Thomas R Ziegler; Roberto A Blanco; Jeffrey D Ritzenthaler; Mauricio Rojas; Jesse Roman; Dean P Jones Journal: PLoS One Date: 2009-03-27 Impact factor: 3.240
Authors: Matthew C Zimmerman; Maysam Takapoo; Dammanahalli K Jagadeesha; Bojana Stanic; Botond Banfi; Ramesh C Bhalla; Francis J Miller Journal: Hypertension Date: 2011-08-01 Impact factor: 10.190
Authors: Jason A Scott; Litao Xie; Hui Li; Weiwei Li; Julie B He; Philip N Sanders; A Brent Carter; Johannes Backs; Mark E Anderson; Isabella M Grumbach Journal: Am J Physiol Heart Circ Physiol Date: 2012-03-16 Impact factor: 4.733
Authors: Shuxia Jiang; Jennifer Streeter; Brandon M Schickling; Kathy Zimmerman; Robert M Weiss; Francis J Miller Journal: Cardiovasc Res Date: 2014-02-05 Impact factor: 10.787
Authors: Shaoping Xu; Amy S Shriver; Dammanahalli K Jagadeesha; Ali H Chamseddine; Katalin Szőcs; Neal L Weintraub; Kathy K Griendling; Ramesh C Bhalla; Francis J Miller Journal: J Vasc Res Date: 2012-03-15 Impact factor: 1.934
Authors: Dammanahalli K Jagadeesha; Maysam Takapoo; Botond Banfi; Ramesh C Bhalla; Francis J Miller Journal: Cardiovasc Res Date: 2011-11-18 Impact factor: 10.787
Authors: Elyse Di Marco; Stephen P Gray; Kit Kennedy; Cedric Szyndralewiez; Alicia N Lyle; Bernard Lassègue; Kathy K Griendling; Mark E Cooper; Harald H H W Schmidt; Karin A M Jandeleit-Dahm Journal: Free Radic Biol Med Date: 2016-07-19 Impact factor: 7.376